F.D.A. resignation: The Food and Drug Administration’s top vaccine and gene therapy official resigned on Tuesday after a ...

This Massachusetts-based biopharmaceutical company announced hundreds of layoffs last week. Here's what the CEO said about it ...

The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...

Separately, Sareptea said last week that it would pause the development of most of its experimental gene therapies for a different type of muscular dystrophy. The stoppage came after one of the ...

Sarepta stock plunged again Thursday on a report the FDA will require additional clinical testing to validate the safety ...

A biopharmaceutical research company with ties in Andover has laid off a third of its workforce as one of the leaders in gene therapy goes through a “strategic ...

Cleveland’s public hospital system cites soaring charity care costs, pandemic relief expiration, and looming bond payments as key drivers of the cuts.

Bloomberg has reported that the layoffs are part of a broader effort to streamline operations and improve decision-making efficiency amid economic pressures.

A recent surge in Northeast Ohio companies requiring employees to return to the office more frequently — or even full-time, in the case of Sherwin Williams — has triggered pushback from ...

As director of the Center for Biologics Evaluation and Research, Dr. Vinay Prasad oversaw the regulation of vaccines and gene therapy drugs such as Sarepta Therapeutics' treatment for Duchenne ...